Henry Woo

Henry Woo is the Head of the Department of Urology at Blacktown Hospital in Sydney, Australia, He is also the Director of Uro-Oncology at the Chris O'Brien Lifehouse Comprehensive Cancer Centre. He is an Honorary Professor at the Australian National University and a Conjoint Professor at the Western Sydney University. His clinical practice is focussed on prostate cancer and the management of male LUTS/BPH. He has authored over 200 peer reviewed publications with many in high impact journals. He currently serves on the editorial boards of multiple journals including the Asian Journal of Urology, Prostate International, World Journal of Men's Health, European Urology Open Science, World Journal of Urology and Prostate Cancer and Prostatic Diseases. He is an Associate Editor of the SIU Journal.

15th August 2025

Time	Session

12:00 13:00	Luncheon Symposium 2【Ferring】 Collaborative Care: Mastering Techniques and Cardiovascular Considerations Welcome Henry WooAustralia Speaker The Art of Care: Techniques to Foster Trust and Empower Patients from a Doctor’s Perspective (Malaysia and Argentina) Henry WooAustralia Moderator Teng-Aik OngMalaysia Speaker Diego DegiovanniArgentina Speaker Mitigate ADT Injection Site Reactions: How I do it? Teng-Aik OngMalaysia Moderator Poh Choo TohSingapore Speaker Optimize cardiovascular risks in ADT treatment: role of patient education Teng-Aik OngMalaysia Moderator Wei-Ting ChangTaiwan Speaker Discussion Closing Teng-Aik OngMalaysia Speaker TICC - 1F 101A

Time

Session

12:00

13:00

Luncheon Symposium 2【Ferring】

Collaborative Care: Mastering Techniques and Cardiovascular Considerations

Welcome

Henry WooAustralia Speaker
The Art of Care: Techniques to Foster Trust and Empower Patients from a Doctor’s Perspective (Malaysia and Argentina)

Henry WooAustralia Moderator

Teng-Aik OngMalaysia Speaker

Diego DegiovanniArgentina Speaker
Mitigate ADT Injection Site Reactions: How I do it?

Teng-Aik OngMalaysia Moderator

Poh Choo TohSingapore Speaker
Optimize cardiovascular risks in ADT treatment: role of patient education

Teng-Aik OngMalaysia Moderator

Wei-Ting ChangTaiwan Speaker
Discussion
Closing

Teng-Aik OngMalaysia Speaker

TICC - 1F 101A

16th August 2025

Time	Session

10:30 12:00	BPH/MIST Crossfire (1): < 100g BPH/MIST Crossfire (1): < 100g Jeff S. ChuehTaiwan Moderator John Jang Hwan KimKorea (Republic of) Moderator Ju-Chuan HuTaiwan Facilitator Jian-Hua HongTaiwan Facilitator Oeng MengleangCambodia Commenter Chung-Cheng WangTaiwan Commenter Dean EltermanCanada Speaker Henry WooAustralia Speaker Peter ChinAustralia Speaker Steffi YuenHong Kong, China Speaker Christopher NetschGermany Speaker TICC - 1F 102
12:00 13:00	Luncheon Symposium 18【Astellas】 (Live) Redefining the Trajectory of Prostate Cancer Redefining the Trajectory of Prostate Cancer Tai-Lung ChaTaiwan Moderator Chun-Te WuTaiwan Moderator Henry WooAustralia Speaker Bertrand TombalBelgium Speaker TICC - 2F 201DE
12:00 13:00	Luncheon Symposium 14【Astellas】 Redefining the Trajectory of Prostate Cancer Redefining the Trajectory of Prostate Cancer Tai-Lung ChaTaiwan Moderator Chun-Te WuTaiwan Moderator Henry WooAustralia Speaker Bertrand TombalBelgium Speaker TICC - 1F 101C	Luncheon Symposium 15【Astellas】 (Live) Redefining the Trajectory of Prostate Cancer Redefining the Trajectory of Prostate Cancer Tai-Lung ChaTaiwan Moderator Chun-Te WuTaiwan Moderator Henry WooAustralia Speaker Bertrand TombalBelgium Speaker TICC - 1F 101D